Bemoaning Virtual Monotherapy In January the Antiviral Drugs Advisory Committee of the FDA met to discuss the trial design for salvage therapy in HIV infection. TAG's Yvette Delph was there and prepared this report. The meeting, chaired by Roy Gulick…
The Cost of Generic Drugs in Brazil Indinavir Efavirenz USA $6,000(1) $4,700 Brazil (generic) $2,928 $2,545 Brazil (Merck 2001) $1,029 $920 "Low" HDI(2) country $600 $500 Price per year per person. Human Development Index of the United Nations, composite…
Merck Makes Surprise Announcement of Human Vaccine Trial, Currently Underway "Still Could Fail" While a handful of companies are testing or have tested potential HIV vaccines in human volunteers, none of these trials have generated nearly as much excitement as…
"We have never been against patents. We have been against monopoly." -- Dr. Yusuf Hamied, CEO, Cipla Dear Sirs: We are writing as a coalition of AIDS treatment advocates, educators, and service providers to request that GlaxoSmithKline immediately withdraw from participation…
An international coalition of 65 activist groups and over 100 AIDS activists, educators, health care workers and service providers from six continents and many countries around the world today called on GlaxoSmithKline, one of the world's largest drug companies, to…
Treatment Paradigms Come and Go, But the Virus and Its Problematic Potions Appear Intractable Prairie Fire "Don't tell me nothin' about no AIDS because that won't impact me. And if I was to get it, all I'd have to do…
Vaccine Study Seen as Significant Advance, But Questions Remain About Human Applicability By David Gold "The Whole Field Energized" Few monkey studies have attracted more attention than one recently published in Science (October 20, 2000). Conducted by Harvard researchers and…
In a letter in response to questions posed by the International Association of Physicians in AIDS Care, Bush said that the primary effort of his administration to fight this "urgent health problem" would be to "support significant government-funded research aimed…
The Global Challenge of Access to Treatment and the Issue of Compulsory Licensing By Mark Harrington December 2000 "We have upside down access to AIDS drugs in this world. The drugs are where the disease is not, and the disease…
December 2000 The arguments over affordable life-saving medicines for the developing world intensified late last month when it was revealed that Glaxo-Wellcome has blocked the importation of inexpensive generic knock-offs of its premier AIDS drug, Combivir, into Ghana (a small…